Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Assets: 2015-2025

Historic Return on Assets for Ascendis Pharma A (ASND) over the last 11 years, with Sep 2025 value amounting to -0.18%.

  • Ascendis Pharma A's Return on Assets rose 26.00% to -0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.18%, marking a year-over-year increase of 26.00%. This contributed to the annual value of -0.38% for FY2024, which is 14.00% up from last year.
  • Per Ascendis Pharma A's latest filing, its Return on Assets stood at -0.18% for Q3 2025, which was up 23.28% from -0.24% recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Assets peaked at -0.18% during Q3 2025, and registered a low of -0.68% during Q3 2023.
  • In the last 3 years, Ascendis Pharma A's Return on Assets had a median value of -0.54% in 2023 and averaged -0.47%.
  • As far as peak fluctuations go, Ascendis Pharma A's Return on Assets skyrocketed by 42bps in 2021, and later crashed by 35bps in 2023.
  • Over the past 5 years, Ascendis Pharma A's Return on Assets (Quarterly) stood at -0.34% in 2021, then fell by 16bps to -0.50% in 2022, then declined by 5bps to -0.55% in 2023, then climbed by 22bps to -0.33% in 2024, then rose by 26bps to -0.18% in 2025.
  • Its Return on Assets stands at -0.18% for Q3 2025, versus -0.24% for Q2 2025 and -0.30% for Q1 2025.